GNF-6231

N/A

Report date: 2022/10/23 12:51:15
NME

Base Information

Drug NameGNF-6231
Drug Alias NameGNF-6231
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-serine O-palmitoleoyltransferase porcupine inhibitorsWnt signalling pathway inhibitors
TargetsProtein-serine O-palmitoleoyltransferase porcupine
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A